Home
Centre for Cancer Biomarkers CCBIO

News archive for Centre for Cancer Biomarkers CCBIO

The Norwegian Research Council and other European research councils are about to make a radical alteration of the scientific publishing model by forcing Open Access for all scientific work. The scheme is called Plan S. 27 Norwegian research leaders, including CCBIO Director Lars A. Akslen, suggest changes to improve the European Plan S Open Access scheme.
CCBIO PhD Candidate Hilde Engerud in the Gynecologic Cancer Research Group was awarded with Best Presentation at the annual meeting of the Norwegian Society for Gynecology and Obstetrics this fall, October 25 and 26 2018.
CCBIO Associate Investigator Daniela Elena Costea received support for 3 years (4.5 milion kr) from Western Norway Regional Health Authority (Helse Vest) for the project "Defining molecular subtypes of head and neck cancer by integrative mutational, stromal and inflammatory landscape analysis".
CCBIO Associate Investigator Dana Costea is currently on a sabbatical at Moores Cancer Center at the University of California, San Diego, and reports of a great learning experience on cell signaling and molecular techniques, collaboration strategies and leadership styles, the center’s exemplary way of collecting tissue samples from patients for research, amazing new colleagues, living in San... Read more
CCBIO PI Donald Gullberg recently returned from an inspiring conference in China, where he was invited speaker for the third National Conference of the Chinese Society of Matrix Biology.
The annual public research event by the scientific and research community in Bergen, the Research Fair ('Forskningstorget'), took this year place September 21st and 22nd. The Bergen Gynecologic Research Group took responsibility for the CCBIO stand this year, and attracted great interest both from adults and the actual target audience, kids and youth.
October 3rd 2018, CCBIO hosted a special seminar titled "The Importance of Mentoring for Career Development", where panellists Marsha A. Moses (Harvard Medical School/Boston Children’s Hospital), Roopali Roy (Harvard Medical School/Boston Children’s Hospital), Roland Jonsson (Faculty of Medicine/UiB) and Anne Blanchard (SVT/CCBIO) discussed mentoring in different forms and settings, and provided... Read more
As the first two weeks of the CCBIO/Harvard Long Course on Cancer-Related Vascular Biology are completed, the attending students report to be greatly inspired by the Harvard scholars who are teaching most classes. This course reflects the INTPART collaboration between CCBIO and the Vascular Biology Program at Boston Children´s Hospital and Harvard Medical School.
19th September 2018, CCBIO hosted a Special Seminar on the issue of scientific excellence. Speakers Bruce Zetter (Harvard Medical School/Boston Children's Hospital), Merle Jacob (Lund University) as well as Lars A. Akslen (CCBIO) and Roger Strand (SVT/CCBIO) discussed different ways to conceptualise and achieve excellence, leaving the audience both inspired and a little thought-provoked.
As a part of the CCBIO-Harvard INTPART collaboration, CCBIO PhD student Silje Kjølle and Medical Student Research Programme students Martha Rolland Jacobsen and Amalie Svanøe were given the opportunity to conduct summer internships at the Vascular Biology Program at Boston Children’s Hospital and Harvard Medical School. They have now returned from Boston, and has provided us with a great report... Read more
Currently UiB/CCBIO have two PhD guest students from Armenia within a collaboration project promoting oral pathology and research (Eurasia program).
Former CCBIO Postdoc Agnete Engelsen was awarded a FRIPRO mobility grant from NFR/ MCA COFUND and is currently resident in France with her family to embark on exciting research projects with distinguished collaborators at Gustave Roussy Cancer Campus Grand Paris. We asked her to report of her life in beautiful Paris.
CCBIO PI Rolf Reed is currently on a sabbatical stay in the US, and we have asked him to share his experience with us.
Bakterier som klamydia kan endre celler og føre til kreft. Det kom frem under Centre for Cancer Biomarkers (CCBIO) sjette årlige symposium på Solstrand.
May and Solstrand showed off with blue skies and warm sunshine when CCBIO hosted the Liquid Biopsy Symposium May 22nd, a satellite symposium to the 6th CCBIO Annual Symposium 2018.
CCBIO PI Anne Christine Johannessen recently returned from a site visit in Sudan to follow up on a longstanding collaboration on oral cancer between Bergen and Khartoum. We asked her to tell us a little about the collaboration.
A research team led by James Lorens at the Department of Biomedicine and CCBIO used new technology to determine how breast tissue changes with age may contribute to breast cancer risk. The research is published in Cell Reports, with a commentary on Eureka Alert.
Maria Paula Ramnefjell defended April 10th 2018 her doctoral thesis "Prognostic biomarkers and clinico-pathologic characteristics in non-small cell lung cancer. A study with special focus on tumor-vascular interactions" at the University of Bergen.

Pages